Syros Pharmaceuticals Announces Publication Of Important Scientific Studies Related To Company's Industry-Leading Gene Control Platform

Published: Dec 18, 2013

free biotech news Get the latest biotech news where you want it. Sign up for the free GenePool newsletter today!

WATERTOWN, Mass.--(BUSINESS WIRE)--Syros Pharmaceuticals, a life sciences company harnessing breakthroughs in gene control to revolutionize the treatment of cancer and other diseases, announced today that papers recently published by Syros Scientific Founders Richard A. Young, Ph.D., and James E. Bradner, M.D., in Cancer Cell and Nature Biotechnology provide further validation of the Syros scientific platform.

Help employers find you! Check out all the jobs and post your resume.

Back to news